Harald Reinhart - 24 May 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld, Attorney-in-Fact
Issuer symbol
ZLAB
Transactions as of
24 May 2021
Net transactions value
-$2,257,840
Form type
4
Filing time
26 May 2021, 20:18:30 UTC
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $167,200 +8,000 $20.90 8,000 24 May 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $1,298,960 -8,000 -100% $162.37* 0 24 May 2021 Direct F1
transaction ZLAB Ordinary Shares Options Exercise $167,200 +8,000 $20.90 8,000 25 May 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $1,293,280 -8,000 -100% $161.66* 0 25 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8,000 -9.5% $0.000000 76,000 24 May 2021 Ordinary Shares 8,000 $20.90 Direct F1, F2
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8,000 -11% $0.000000 68,000 25 May 2021 Ordinary Shares 8,000 $20.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant.